[Controversial issues concerning the initial treatment of Parkinson's disease: L-Dopa or dopaminergic agonists?].
Defer
G L
GL
Service de Neurologie Déjerine, CHU de la Côte de Nacre, Caen.
D000978:Antiparkinson Agents / Q000627:therapeutic use*; D018491:Dopamine Agonists / Q000627:therapeutic use*; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*; D013997:Time Factors
D000978:Antiparkinson Agents; D018491:Dopamine Agonists; D007980:Levodopa